Repurposing of aging‐preventive pharmaceuticals to delay Alzheimer's disease progression.
AAIC 2025 Abstract
Abstract
Background: Aging is the main risk factor for Alzheimer’s disease (AD). Several approved drugs currently used to treat conditions such as high blood pressure and diabetes may also influence the aging process, holding significant potential to delay AD onset or its progression.
- Calcium channel blockers
- GLP-1 receptor agonists
- GLP-1 and incretin signalling
- Alzheimer's disease
- Dementia
- Humans
